Depletion of carbonic anhydrase IX abrogates hypoxia-induced overexpression of stanniocalcin-1 in triple negative breast cancer cells

References

• Li Y, Tu C, Wang H, Silverman DN, Frost SC. Catalysis and pH control by membrane-associated carbonic anhydrase IX in MDA-MB-231 breast cancer cells. J Biol Chem 2011; 286:15789-96; PMID:21454639; https://doi.org/10.1074/jbc.M110.188524
   PubMed Web of Science ®Google Scholar
• Svastova E, Zilka N, Zat'ovicova M, Gibadulinova A, Ciampor F, Pastorek J, Pastorekova S. Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with beta-catenin. Exp Cell Res 2003; 290:332-45; PMID:14567991; https://doi.org/10.1016/S0014-4827(03)00351-3
   PubMed Web of Science ®Google Scholar
• Csaderova L, Debreova M, Radvak P, Stano M, Vrestiakova M, Kopacek J, Pastorekova S, Svastova E. The effect of carbonic anhydrase IX on focal contacts during cell spreading and migration. Front Physiol 2013; 4:271; PMID:24101905; https://doi.org/10.3389/fphys.2013.00271
   PubMed Web of Science ®Google Scholar
• Leppilampi M, Karttunen TJ, Kivela J, Gut MO, Pastorekova S, Pastorek J, Parkkila S. Gastric pit cell hyperplasia and glandular atrophy in carbonic anhydrase IX knockout mice: studies on two strains C57/BL6 and BALB/C. Transgenic Res 2005; 14:655-63; PMID:16245156; https://doi.org/10.1007/s11248-005-7215-z
   PubMed Web of Science ®Google Scholar
• Ondriskova E, Debreova M, Pastorekova S. Chapter 10 - tumor-associated carbonic anhydrases IX and XII A2 - Supuran, Claudiu T. In: Simone GD, ed. Carbonic anhydrases as biocatalysts. Amsterdam: Elsevier, 2015:169-205; https://doi.org/10.1016/B978-0-444-63258-6.00010-X
   Google Scholar
• Gut MO, Parkkila S, Vernerova Z, Rohde E, Zavada J, Hocker M, Pastorek J, Karttunen T, Gibadulinova A, Zavadova Z, et al. Gastric hyperplasia in mice with targeted disruption of the carbonic anhydrase gene Car9. Gastroenterology 2002; 123:1889-903; PMID:12454846; https://doi.org/10.1053/gast.2002.37052
   PubMed Web of Science ®Google Scholar
• Trastour C, Benizri E, Ettore F, Ramaioli A, Chamorey E, Pouyssegur J, Berra E. HIF-1alpha and CA IX staining in invasive breast carcinomas: Prognosis and treatment outcome. Int J Cancer 2007; 120:1451-8; PMID:17245699; https://doi.org/10.1002/ijc.22436
   PubMed Web of Science ®Google Scholar
• Tan EY, Yan M, Campo L, Han C, Takano E, Turley H, Candiloro I, Pezzella F, Gatter KC, Millar EK, et al. The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy. Br J Cancer 2009; 100:405-11; PMID:19165203; https://doi.org/10.1038/sj.bjc.6604844
   PubMed Web of Science ®Google Scholar
• Lou Y, McDonald PC, Oloumi A, Chia S, Ostlund C, Ahmadi A, Kyle A, Auf dem KU, Leung S, Huntsman D, et al. Targeting tumor hypoxia: Suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. Cancer Res 2011; 71:3364-76; PMID:21415165; https://doi.org/10.1158/0008-5472.CAN-10-4261
   PubMed Web of Science ®Google Scholar
• Chen CL, Chu JS, Su WC, Huang SC, Lee WY. Hypoxia and metabolic phenotypes during breast carcinogenesis: Expression of HIF-1alpha, GLUT1, and CAIX. Virchows Arch 2010; 457:53-61; PMID:20526721; https://doi.org/10.1007/s00428-010-0938-0
   PubMed Web of Science ®Google Scholar
• Ivanova L, Zandberga E, Silina K, Kalnina Z, Abols A, Endzelins E, Vendina I, Romanchikova N, Hegmane A, Trapencieris P, et al. Prognostic relevance of carbonic anhydrase IX expression is distinct in various subtypes of breast cancer and its silencing suppresses self-renewal capacity of breast cancer cells. Cancer Chemother Pharmacol 2015; 75:235-46; PMID:25422154; https://doi.org/10.1007/s00280-014-2635-1
   PubMed Web of Science ®Google Scholar
• Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell 2012; 148:399-408; PMID:22304911; https://doi.org/10.1016/j.cell.2012.01.021
   PubMed Web of Science ®Google Scholar
• Mazzio EA, Smith B, Soliman KF. Evaluation of endogenous acidic metabolic products associated with carbohydrate metabolism in tumor cells. Cell Biol Toxicol 2010; 26:177-88; PMID:19784859; https://doi.org/10.1007/s10565-009-9138-6
   PubMed Web of Science ®Google Scholar
• Chiche J, Ilc K, Laferriere J, Trottier E, Dayan F, Mazure NM, Brahimi-Horn MC, Pouyssegur J. Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Res 2009; 69:358-68; PMID:19118021; https://doi.org/10.1158/0008-5472.CAN-08-2470
   PubMed Web of Science ®Google Scholar
• Adams DJ, Wahl ML, Flowers JL, Sen B, Colvin M, Dewhirst MW, Manikumar G, Wani MC. Camptothecin analogs with enhanced activity against human breast cancer cells. II. Impact of the tumor pH gradient. Cancer Chemother Pharmacol 2006; 57:145-54; PMID:16001167; https://doi.org/10.1007/s00280-005-0008-5
   PubMed Web of Science ®Google Scholar
• Webster KA, Discher DJ, Kaiser S, Hernandez O, Sato B, Bishopric NH. Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53. J Clin Invest 1999; 104:239-52; PMID:10430605; https://doi.org/10.1172/JCI5871
   PubMed Web of Science ®Google Scholar
• Gupta SC, Singh R, Pochampally R, Watabe K, Mo YY. Acidosis promotes invasiveness of breast cancer cells through ROS-AKT-NF-kappaB pathway. Oncotarget 2014; 5:12070-82; PMID:25504433; https://doi.org/10.18632/oncotarget.2514
   PubMed Web of Science ®Google Scholar
• Hjelmeland AB, Wu Q, Heddleston JM, Choudhary GS, MacSwords J, Lathia JD, McLendon R, Lindner D, Sloan A, Rich JN. Acidic stress promotes a glioma stem cell phenotype. Cell Death Differ 2011; 18:829-40; PMID:21127501; https://doi.org/10.1038/cdd.2010.150
   PubMed Web of Science ®Google Scholar
• Kaluz S, Kaluzova M, Liao SY, Lerman M, Stanbridge EJ. Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show? Biochim Biophys Acta 2009; 1795:162-72; PMID:19344680; https://doi.org/10.1016/j.bbcan.2009.01.001
   PubMed Web of Science ®Google Scholar
• Tafreshi NK, Lloyd MC, Proemsey JB, Bui MM, Kim J, Gillies RJ, Morse DL. Evaluation of CAIX and CAXII expression in breast cancer at varied O2 Levels: CAIX is the superior surrogate imaging biomarker of tumor hypoxia. Mol Imaging Biol 2016; 18:219-31; PMID:26276155; https://doi.org/10.1007/s11307-015-0885-x
   PubMed Web of Science ®Google Scholar
• McDonald PC, Winum JY, Supuran CT, Dedhar S. Recent developments in targeting carbonic anhydrase IX for cancer therapeutics. Oncotarget 2012; 3:84-97; PMID:22289741; https://doi.org/10.18632/oncotarget.422
   PubMed Web of Science ®Google Scholar
• Chiche J, Ilc K, Brahimi-Horn MC, Pouyssegur J. Membrane-bound carbonic anhydrases are key pH regulators controlling tumor growth and cell migration. Adv Enzyme Regul 2010; 50:20-33; PMID:19895836; https://doi.org/10.1016/j.advenzreg.2009.10.005
   PubMedGoogle Scholar
• Hussain SA, Ganesan R, Reynolds G, Gross L, Stevens A, Pastorek J, Murray PG, Perunovic B, Anwar MS, Billingham L, et al. Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer. Br J Cancer 2007; 96:104-9; PMID:17213826; https://doi.org/10.1038/sj.bjc.6603530
   PubMed Web of Science ®Google Scholar
• Bernardi R, Gianni L. Hallmarks of triple negative breast cancer are emerging at last? Cell Res 2014; 24:904-5; PMID:24810303; https://doi.org/10.1038/cr.2014.61
   PubMed Web of Science ®Google Scholar
• Ward C, Meehan J, Mullen P, Supuran C, Dixon JM, Thomas JS, Winum JY, Lambin P, Dubois L, Pavathaneni NK, et al. Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models. Oncotarget 2015; 6:24856-70; PMID:26259239; https://doi.org/10.18632/oncotarget.4498
   PubMed Web of Science ®Google Scholar
• Jeon M, Han J, Nam SJ, Lee JE, Kim S. STC-1 expression is upregulated through an Akt/NF-kappaB-dependent pathway in triple-negative breast cancer cells. Oncol Rep 2016; 36:1717-22; PMID:27461417; https://doi.org/10.3892/or.2016.4972
   PubMed Web of Science ®Google Scholar
• Chang AC, Doherty J, Huschtscha LI, Redvers R, Restall C, Reddel RR, Anderson RL. STC1 expression is associated with tumor growth and metastasis in breast cancer. Clin Exp Metastasis 2015; 32:15-27; PMID:25391215; https://doi.org/10.1007/s10585-014-9687-9
   PubMed Web of Science ®Google Scholar
• Ma X, Gu L, Li H, Gao Y, Li X, Shen D, Gong H, Li S, Niu S, Zhang Y, et al. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma. J Transl Med 2015; 13:56; PMID:25740019; https://doi.org/10.1186/s12967-015-0421-4
   PubMed Web of Science ®Google Scholar
• Li Y, Wang H, Oosterwijk E, Tu C, Shiverick KT, Silverman DN, Frost SC. Expression and activity of carbonic anhydrase IX is associated with metabolic dysfunction in MDA-MB-231 breast cancer cells. Cancer Invest 2009; 27:613-23; PMID:19367501; https://doi.org/10.1080/07357900802653464
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008; 7:168-81; PMID:18167490; https://doi.org/10.1038/nrd2467
   PubMed Web of Science ®Google Scholar
• Mihaly Z, Kormos M, Lanczky A, Dank M, Budczies J, Szasz MA, Gyorffy B. A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer. Breast Cancer Res Treat 2013; 140:219-32; PMID:23836010; https://doi.org/10.1007/s10549-013-2622-y
   PubMed Web of Science ®Google Scholar
• Grabmaier K, Vissers JL, De Weijert MC, Oosterwijk-Wakka JC, Van Bokhoven A, Brakenhoff RH, Noessner E, Mulders PA, Merkx G, Figdor CG, et al. Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250. Int J Cancer 2000; 85:865-70; PMID:10709109; https://doi.org/10.1002/(SICI)1097-0215(20000315)85:6%3c865::AID-IJC21%3e3.0.CO;2-Q
   PubMed Web of Science ®Google Scholar
• Siebels M, Rohrmann K, Oberneder R, Stahler M, Haseke N, Beck J, Hofmann R, Kindler M, Kloepfer P, Stief C. A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX(R)) and interferon-alpha-2a in metastatic renal cell carcinoma patients. World J Urol 2011; 29:121-6; PMID:20512580; https://doi.org/10.1007/s00345-010-0570-2
   PubMed Web of Science ®Google Scholar
• Chamie K, Donin NM, Klopfer P, Bevan P, Fall B, Wilhelm O, Storkel S, Said J, Gambla M, Hawkins RE, et al. Adjuvant weekly girentuximab following nephrectomy for high-risk renal cell carcinoma: The ARISER randomized clinical trial. JAMA Oncol 2016; 3:913-920; PMID:27787547; https://doi.org/10.1001/jamaoncol.2016.4419
   PubMed Web of Science ®Google Scholar
• Paolicchi E, Gemignani F, Krstic-Demonacos M, Dedhar S, Mutti L, Landi S. Targeting hypoxic response for cancer therapy. Oncotarget 2016; 7:13464-78; PMID:26859576; https://doi.org/10.18632/oncotarget.7229
   PubMed Web of Science ®Google Scholar
• Lock FE, McDonald PC, Lou Y, Serrano I, Chafe SC, Ostlund C, Aparicio S, Winum JY, Supuran CT, Dedhar S. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche. Oncogene 2013; 32:5210-9; PMID:23208505; https://doi.org/10.1038/onc.2012.550
   PubMed Web of Science ®Google Scholar
• Shin HJ, Rho SB, Jung DC, Han IO, Oh ES, Kim JY. Carbonic anhydrase IX (CA9) modulates tumor-associated cell migration and invasion. J Cell Sci 2011; 124:1077-87; PMID:21363891; https://doi.org/10.1242/jcs.072207
   PubMed Web of Science ®Google Scholar
• Radvak P, Repic M, Svastova E, Takacova M, Csaderova L, Strnad H, Pastorek J, Pastorekova S, Kopacek J. Suppression of carbonic anhydrase IX leads to aberrant focal adhesion and decreased invasion of tumor cells. Oncol Rep 2013; 29:1147-53; PMID:23291973; https://doi.org/10.3892/or.2013.2226
   PubMed Web of Science ®Google Scholar
• Pan JS, Huang L, Belousova T, Lu L, Yang Y, Reddel R, Chang A, Ju H, DiMattia G, Tong Q, et al. Stanniocalcin-1 inhibits renal ischemia/reperfusion injury via an AMP-activated protein kinase-dependent pathway. J Am Soc Nephrol 2015; 26:364-78; PMID:25012175; https://doi.org/10.1681/ASN.2013070703
   PubMed Web of Science ®Google Scholar
• Ohkouchi S, Ono M, Kobayashi M, Hirano T, Tojo Y, Hisata S, Ichinose M, Irokawa T, Ogawa H, Kurosawa H. Myriad functions of stanniocalcin-1 (STC1) cover multiple therapeutic targets in the complicated pathogenesis of Idiopathic Pulmonary Fibrosis (IPF). Clin Med Insights Circ Respir Pulm Med 2015; 9:91-6; PMID:26740747; https://doi.org/10.4137/CCRPM.S23285
   PubMed Web of Science ®Google Scholar
• Koizumi K, Hoshiai M, Ishida H, Ohyama K, Sugiyama H, Naito A, Toda T, Nakazawa H, Nakazawa S. Stanniocalcin 1 prevents cytosolic Ca2+ overload and cell hypercontracture in cardiomyocytes. Circ J 2007; 71:796-801; PMID:17457011; https://doi.org/10.1253/circj.71.796
   PubMed Web of Science ®Google Scholar
• Rezapour S, Bahrami T, Hashemzadeh S, Estiar MA, Nemati M, Ravanbakhsh R, Feizi MA, Kafil HS, Pouladi N, Ghojazadeh M, et al. STC1 and NF-kappaB p65 (Rel A) is constitutively activated in colorectal cancer. Clin Lab 2016; 62:463-9; PMID:27156337; https://doi.org/10.7754/Clin.Lab.2015.150827
   PubMed Web of Science ®Google Scholar
• Du YZ, Gu XH, Cheng SF, Li L, Liu H, Hu LP, Gao F. The oncogenetic role of stanniocalcin 1 in lung adenocarcinoma: A promising serum candidate biomarker for tracking lung adenocarcinoma progression. Tumour Biol 2016; 37:5633-44; PMID:26577859; https://doi.org/10.1007/s13277-015-4431-x
   PubMed Web of Science ®Google Scholar
• Su J, Guo B, Zhang T, Wang K, Li X, Liang G. Stanniocalcin-1, a new biomarker of glioma progression, is associated with prognosis of patients. Tumour Biol 2015; 36:6333-9; PMID:25783529; https://doi.org/10.1007/s13277-015-3319-0
   PubMed Web of Science ®Google Scholar
• Ito Y, Zemans R, Correll K, Yang IV, Ahmad A, Gao B, Mason RJ. Stanniocalcin-1 is induced by hypoxia inducible factor in rat alveolar epithelial cells. Biochem Biophys Res Commun 2014; 452:1091-7; PMID:25251473; https://doi.org/10.1016/j.bbrc.2014.09.060
   PubMed Web of Science ®Google Scholar
• Durukan Tolvanen A, Westberg JA, Serlachius M, Chang AC, Reddel RR, Andersson LC, Tatlisumak T. Stanniocalcin 1 is important for poststroke functionality, but dispensable for ischemic tolerance. Neuroscience 2013; 229:49-54; PMID:23159313; https://doi.org/10.1016/j.neuroscience.2012.10.062
   PubMed Web of Science ®Google Scholar
• Yeung BH, Law AY, Wong CK. Evolution and roles of stanniocalcin. Mol Cell Endocrinol 2012; 349:272-80; PMID:22115958; https://doi.org/10.1016/j.mce.2011.11.007
   PubMed Web of Science ®Google Scholar
• Shi X, Wang J, Qin Y. Recombinant adeno-associated virus-delivered hypoxia-inducible stanniocalcin-1 expression effectively inhibits hypoxia-induced cell apoptosis in cardiomyocytes. J Cardiovasc Pharmacol 2014; 64:522-9; PMID:25490418; https://doi.org/10.1097/FJC.0000000000000146
   PubMed Web of Science ®Google Scholar
• Abaza HM, Elmougy MI, El Maraghy HM, Mahmoud HM. Stanniocalcin1 gene expression in patients with acute leukemia: Impact on response to therapy and disease outcome. Int J Lab Hematol 2016; 38:81-9; PMID:26547904; https://doi.org/10.1111/ijlh.12445
   PubMed Web of Science ®Google Scholar
• Dai D, Wang Q, Li X, Liu J, Ma X, Xu W. Klotho inhibits human follicular thyroid cancer cell growth and promotes apoptosis through regulation of the expression of stanniocalcin-1. Oncol Rep 2016; 35:552-8; PMID:26531219; https://doi.org/10.3892/or.2015.4358
   PubMed Web of Science ®Google Scholar
• Han J, Jeon M, Shin I, Kim S. Elevated STC1 augments the invasiveness of triplenegative breast cancer cells through activation of the JNK/cJun signaling pathway. Oncol Rep 2016; 36:1764-71; PMID:27459971; https://doi.org/10.3892/or.2016.4977
   PubMed Web of Science ®Google Scholar
• Tafreshi NK, Bui MM, Bishop K, Lloyd MC, Enkemann SA, Lopez AS, Abrahams D, Carter BW, Vagner J, Grobmyer SR, et al. Noninvasive detection of breast cancer lymph node metastasis using carbonic anhydrases IX and XII targeted imaging probes. Clin Cancer Res 2012; 18:207-19; PMID:22016510; https://doi.org/10.1158/1078-0432.CCR-11-0238
   PubMed Web of Science ®Google Scholar
• Law AY, Ching LY, Lai KP, Wong CK. Identification and characterization of the hypoxia-responsive element in human stanniocalcin-1 gene. Mol Cell Endocrinol 2010; 314:118-27; PMID:19628018; https://doi.org/10.1016/j.mce.2009.07.007
   PubMed Web of Science ®Google Scholar
• Chafe SC, Lou Y, Sceneay J, Vallejo M, Hamilton MJ, McDonald PC, Bennewith KL, Moller A, Dedhar S. Carbonic anhydrase IX promotes myeloid-derived suppressor cell mobilization and establishment of a metastatic niche by stimulating G-CSF production. Cancer Res 2015; 75:996-1008; PMID:25623234; https://doi.org/10.1158/0008-5472.CAN-14-3000
   PubMed Web of Science ®Google Scholar
• Kim BR, Shin HJ, Kim JY, Byun HJ, Lee JH, Sung YK, Rho SB. Dickkopf-1 (DKK-1) interrupts FAK/PI3K/mTOR pathway by interaction of carbonic anhydrase IX (CA9) in tumorigenesis. Cell Signal 2012; 24:1406-13; PMID:22430125; https://doi.org/10.1016/j.cellsig.2012.03.002
   PubMed Web of Science ®Google Scholar
• Richmond A. Nf-kappa B, chemokine gene transcription and tumour growth. Nat Rev Immunol 2002; 2:664-74; PMID:12209135; https://doi.org/10.1038/nri887
   PubMed Web of Science ®Google Scholar